Structure

Physi-Chem Properties

Molecular Weight:  594.27
Volume:  582.874
LogP:  1.402
LogD:  1.848
LogS:  -2.742
# Rotatable Bonds:  14
TPSA:  198.76
# H-Bond Aceptor:  12
# H-Bond Donor:  8
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.137
Synthetic Accessibility Score:  4.482
Fsp3:  0.6
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.175
MDCK Permeability:  1.0424860192870256e-05
Pgp-inhibitor:  0.008
Pgp-substrate:  0.616
Human Intestinal Absorption (HIA):  0.995
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.065
Plasma Protein Binding (PPB):  94.63504791259766%
Volume Distribution (VD):  0.175
Pgp-substrate:  2.7518608570098877%

ADMET: Metabolism

CYP1A2-inhibitor:  0.03
CYP1A2-substrate:  0.023
CYP2C19-inhibitor:  0.062
CYP2C19-substrate:  0.086
CYP2C9-inhibitor:  0.057
CYP2C9-substrate:  0.68
CYP2D6-inhibitor:  0.07
CYP2D6-substrate:  0.172
CYP3A4-inhibitor:  0.012
CYP3A4-substrate:  0.078

ADMET: Excretion

Clearance (CL):  1.429
Half-life (T1/2):  0.817

ADMET: Toxicity

hERG Blockers:  0.364
Human Hepatotoxicity (H-HT):  0.054
Drug-inuced Liver Injury (DILI):  0.02
AMES Toxicity:  0.298
Rat Oral Acute Toxicity:  0.183
Maximum Recommended Daily Dose:  0.04
Skin Sensitization:  0.956
Carcinogencity:  0.266
Eye Corrosion:  0.003
Eye Irritation:  0.137
Respiratory Toxicity:  0.015

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471067

Natural Product ID:  NPC471067
Common Name*:   (3R)-1,7-Bis-(4-Hydroxyphenyl)-3-Heptanol-3-O-Beta-D-Apiofuranosyl-(1->6)-Beta-D-Glucopyranoside
IUPAC Name:   (2R,3R,4S,5S,6R)-2-[(3R)-1,7-bis(4-hydroxyphenyl)heptan-3-yl]oxy-6-[[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]oxane-3,4,5-triol
Synonyms:  
Standard InCHIKey:  GEZFOHOYLWPGPK-DQKXWWCFSA-N
Standard InCHI:  InChI=1S/C30H42O12/c31-15-22-24(34)27(37)29(41-22)39-16-23-25(35)26(36)28(38)30(42-23)40-21(14-9-18-7-12-20(33)13-8-18)4-2-1-3-17-5-10-19(32)11-6-17/h5-8,10-13,21-38H,1-4,9,14-16H2/t21-,22-,23-,24-,25-,26+,27-,28-,29-,30-/m1/s1
SMILES:  OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)OC[C@H]1O[C@@H](O[C@@H](CCc2ccc(cc2)O)CCCCc2ccc(cc2)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2346811
PubChem CID:   71718346
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32876 alnus hirsuta f. sibirica Species Betulaceae Eukaryota n.a. n.a. n.a. PMID[23465614]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT520 Cell Line 3T3-L1 Mus musculus Activity = 92.9 % PMID[565960]
NPT520 Cell Line 3T3-L1 Mus musculus Activity = 92.1 % PMID[565960]
NPT520 Cell Line 3T3-L1 Mus musculus Activity = 79.6 % PMID[565960]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471067 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9914 High Similarity NPC178449
0.9914 High Similarity NPC232454
0.9914 High Similarity NPC470907
0.9826 High Similarity NPC469704
0.9826 High Similarity NPC469703
0.9826 High Similarity NPC160854
0.9826 High Similarity NPC201402
0.9741 High Similarity NPC469686
0.9583 High Similarity NPC469687
0.9569 High Similarity NPC282409
0.9569 High Similarity NPC469702
0.9487 High Similarity NPC476448
0.9487 High Similarity NPC469548
0.9487 High Similarity NPC476445
0.9262 High Similarity NPC108659
0.9262 High Similarity NPC231607
0.9262 High Similarity NPC79715
0.9262 High Similarity NPC264900
0.9244 High Similarity NPC55608
0.9224 High Similarity NPC148055
0.9217 High Similarity NPC157338
0.92 High Similarity NPC471095
0.92 High Similarity NPC471066
0.918 High Similarity NPC94179
0.9127 High Similarity NPC164172
0.912 High Similarity NPC478255
0.9113 High Similarity NPC184092
0.904 High Similarity NPC470122
0.904 High Similarity NPC469705
0.904 High Similarity NPC17968
0.9032 High Similarity NPC225307
0.8952 High Similarity NPC288416
0.8943 High Similarity NPC90318
0.8898 High Similarity NPC473556
0.8898 High Similarity NPC254275
0.8898 High Similarity NPC175771
0.8898 High Similarity NPC301651
0.8889 High Similarity NPC313193
0.888 High Similarity NPC158673
0.888 High Similarity NPC148982
0.8846 High Similarity NPC469696
0.8819 High Similarity NPC235294
0.8819 High Similarity NPC46137
0.877 High Similarity NPC266045
0.8682 High Similarity NPC28637
0.8672 High Similarity NPC225384
0.8672 High Similarity NPC246869
0.8672 High Similarity NPC138777
0.8672 High Similarity NPC476407
0.8651 High Similarity NPC45224
0.8651 High Similarity NPC173150
0.8651 High Similarity NPC471881
0.8651 High Similarity NPC35288
0.8651 High Similarity NPC156692
0.8651 High Similarity NPC471882
0.8647 High Similarity NPC472711
0.864 High Similarity NPC83218
0.864 High Similarity NPC126991
0.8636 High Similarity NPC328273
0.8636 High Similarity NPC321638
0.8636 High Similarity NPC171134
0.8636 High Similarity NPC321184
0.8626 High Similarity NPC52277
0.8626 High Similarity NPC199459
0.8626 High Similarity NPC177035
0.8571 High Similarity NPC61181
0.8571 High Similarity NPC471157
0.856 High Similarity NPC287429
0.8559 High Similarity NPC42911
0.8559 High Similarity NPC153795
0.8559 High Similarity NPC290353
0.855 High Similarity NPC79957
0.855 High Similarity NPC263829
0.8548 High Similarity NPC476142
0.8548 High Similarity NPC52097
0.8519 High Similarity NPC185307
0.8519 High Similarity NPC46092
0.8519 High Similarity NPC477898
0.8519 High Similarity NPC470950
0.8516 High Similarity NPC469549
0.8504 High Similarity NPC106677
0.8504 High Similarity NPC103533
0.8496 Intermediate Similarity NPC156376
0.848 Intermediate Similarity NPC212176
0.8473 Intermediate Similarity NPC287597
0.8473 Intermediate Similarity NPC476411
0.8473 Intermediate Similarity NPC34293
0.8473 Intermediate Similarity NPC886
0.8468 Intermediate Similarity NPC11724
0.8456 Intermediate Similarity NPC283995
0.8456 Intermediate Similarity NPC129417
0.8456 Intermediate Similarity NPC84181
0.8456 Intermediate Similarity NPC470235
0.8444 Intermediate Similarity NPC476356
0.8444 Intermediate Similarity NPC472353
0.8433 Intermediate Similarity NPC106944
0.8425 Intermediate Similarity NPC252114
0.8421 Intermediate Similarity NPC260425
0.8421 Intermediate Similarity NPC262328
0.8421 Intermediate Similarity NPC138738
0.8421 Intermediate Similarity NPC87777
0.8421 Intermediate Similarity NPC470413
0.8409 Intermediate Similarity NPC180171
0.8409 Intermediate Similarity NPC123988
0.8409 Intermediate Similarity NPC158325
0.8409 Intermediate Similarity NPC103398
0.8394 Intermediate Similarity NPC279298
0.8394 Intermediate Similarity NPC38041
0.8394 Intermediate Similarity NPC18979
0.8394 Intermediate Similarity NPC22150
0.8387 Intermediate Similarity NPC269242
0.8387 Intermediate Similarity NPC476872
0.8387 Intermediate Similarity NPC198734
0.8387 Intermediate Similarity NPC469412
0.8385 Intermediate Similarity NPC475824
0.8385 Intermediate Similarity NPC475067
0.8382 Intermediate Similarity NPC478250
0.8382 Intermediate Similarity NPC40305
0.8382 Intermediate Similarity NPC105005
0.837 Intermediate Similarity NPC471908
0.8361 Intermediate Similarity NPC476266
0.8358 Intermediate Similarity NPC205195
0.8358 Intermediate Similarity NPC472350
0.8358 Intermediate Similarity NPC197316
0.8358 Intermediate Similarity NPC81515
0.8358 Intermediate Similarity NPC89105
0.8358 Intermediate Similarity NPC64141
0.8358 Intermediate Similarity NPC68092
0.8358 Intermediate Similarity NPC476383
0.8346 Intermediate Similarity NPC470510
0.8346 Intermediate Similarity NPC471345
0.8333 Intermediate Similarity NPC470881
0.8333 Intermediate Similarity NPC169398
0.8333 Intermediate Similarity NPC187194
0.8333 Intermediate Similarity NPC35731
0.8333 Intermediate Similarity NPC112861
0.8321 Intermediate Similarity NPC303422
0.8321 Intermediate Similarity NPC85799
0.8321 Intermediate Similarity NPC473046
0.8321 Intermediate Similarity NPC26080
0.8321 Intermediate Similarity NPC187774
0.8321 Intermediate Similarity NPC472712
0.8321 Intermediate Similarity NPC300894
0.8321 Intermediate Similarity NPC118385
0.8321 Intermediate Similarity NPC196063
0.8321 Intermediate Similarity NPC165686
0.8321 Intermediate Similarity NPC472713
0.8321 Intermediate Similarity NPC141455
0.8321 Intermediate Similarity NPC296954
0.8309 Intermediate Similarity NPC246947
0.8306 Intermediate Similarity NPC60589
0.8306 Intermediate Similarity NPC469708
0.8284 Intermediate Similarity NPC84789
0.8284 Intermediate Similarity NPC310252
0.8284 Intermediate Similarity NPC304152
0.8284 Intermediate Similarity NPC78363
0.8284 Intermediate Similarity NPC302583
0.8284 Intermediate Similarity NPC100558
0.8273 Intermediate Similarity NPC114505
0.8273 Intermediate Similarity NPC15956
0.8273 Intermediate Similarity NPC31325
0.8273 Intermediate Similarity NPC193473
0.8273 Intermediate Similarity NPC275284
0.8273 Intermediate Similarity NPC224674
0.8273 Intermediate Similarity NPC39657
0.8273 Intermediate Similarity NPC213074
0.8271 Intermediate Similarity NPC101624
0.8271 Intermediate Similarity NPC184938
0.8261 Intermediate Similarity NPC43508
0.8261 Intermediate Similarity NPC476301
0.8261 Intermediate Similarity NPC469586
0.8258 Intermediate Similarity NPC294166
0.8258 Intermediate Similarity NPC115022
0.8258 Intermediate Similarity NPC6836
0.8258 Intermediate Similarity NPC215037
0.8248 Intermediate Similarity NPC113680
0.8248 Intermediate Similarity NPC278961
0.8244 Intermediate Similarity NPC254819
0.8244 Intermediate Similarity NPC65942
0.8244 Intermediate Similarity NPC219677
0.8244 Intermediate Similarity NPC121376
0.8244 Intermediate Similarity NPC281798
0.8244 Intermediate Similarity NPC248307
0.8235 Intermediate Similarity NPC469661
0.8235 Intermediate Similarity NPC210192
0.8235 Intermediate Similarity NPC264784
0.8235 Intermediate Similarity NPC476385
0.8235 Intermediate Similarity NPC476377
0.8235 Intermediate Similarity NPC47471
0.8235 Intermediate Similarity NPC134405
0.8235 Intermediate Similarity NPC108674
0.8231 Intermediate Similarity NPC253595
0.8214 Intermediate Similarity NPC120728
0.8209 Intermediate Similarity NPC40664
0.8209 Intermediate Similarity NPC166180
0.8209 Intermediate Similarity NPC469383
0.8209 Intermediate Similarity NPC138350
0.8209 Intermediate Similarity NPC197723
0.8209 Intermediate Similarity NPC3293
0.8209 Intermediate Similarity NPC165482

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471067 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8358 Intermediate Similarity NPD7266 Discontinued
0.8031 Intermediate Similarity NPD1091 Approved
0.7874 Intermediate Similarity NPD5125 Phase 3
0.7874 Intermediate Similarity NPD5126 Approved
0.7676 Intermediate Similarity NPD5058 Phase 3
0.7586 Intermediate Similarity NPD2859 Approved
0.7586 Intermediate Similarity NPD2860 Approved
0.7556 Intermediate Similarity NPD3027 Phase 3
0.7518 Intermediate Similarity NPD1613 Approved
0.7518 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2934 Approved
0.75 Intermediate Similarity NPD2933 Approved
0.7482 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD5588 Approved
0.7407 Intermediate Similarity NPD2861 Phase 2
0.74 Intermediate Similarity NPD8455 Phase 2
0.7395 Intermediate Similarity NPD3020 Approved
0.7388 Intermediate Similarity NPD3094 Phase 2
0.7381 Intermediate Similarity NPD7843 Approved
0.7368 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7328 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.728 Intermediate Similarity NPD3022 Approved
0.728 Intermediate Similarity NPD3021 Approved
0.7234 Intermediate Similarity NPD4536 Approved
0.7234 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD4538 Approved
0.7226 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD4908 Phase 1
0.7222 Intermediate Similarity NPD6674 Discontinued
0.7218 Intermediate Similarity NPD3092 Approved
0.7218 Intermediate Similarity NPD1610 Phase 2
0.7218 Intermediate Similarity NPD3705 Approved
0.7215 Intermediate Similarity NPD7228 Approved
0.7209 Intermediate Similarity NPD7157 Approved
0.72 Intermediate Similarity NPD2684 Approved
0.7183 Intermediate Similarity NPD5960 Phase 3
0.7181 Intermediate Similarity NPD1653 Approved
0.7176 Intermediate Similarity NPD1548 Phase 1
0.7153 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7131 Intermediate Similarity NPD846 Approved
0.7131 Intermediate Similarity NPD940 Approved
0.7123 Intermediate Similarity NPD6190 Approved
0.7122 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD1357 Approved
0.7113 Intermediate Similarity NPD7097 Phase 1
0.7111 Intermediate Similarity NPD4659 Approved
0.7107 Intermediate Similarity NPD3818 Discontinued
0.7105 Intermediate Similarity NPD37 Approved
0.7097 Intermediate Similarity NPD6234 Discontinued
0.7078 Intermediate Similarity NPD4967 Phase 2
0.7078 Intermediate Similarity NPD4966 Approved
0.7078 Intermediate Similarity NPD4965 Approved
0.7071 Intermediate Similarity NPD6407 Approved
0.7071 Intermediate Similarity NPD6405 Approved
0.7068 Intermediate Similarity NPD5846 Approved
0.7068 Intermediate Similarity NPD6516 Phase 2
0.7063 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD1242 Phase 1
0.7045 Intermediate Similarity NPD3091 Approved
0.7037 Intermediate Similarity NPD6559 Discontinued
0.7031 Intermediate Similarity NPD969 Suspended
0.7027 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD7074 Phase 3
0.7007 Intermediate Similarity NPD4104 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD4103 Phase 2
0.6986 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6974 Remote Similarity NPD4380 Phase 2
0.6966 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7054 Approved
0.695 Remote Similarity NPD6233 Phase 2
0.6934 Remote Similarity NPD8651 Approved
0.6917 Remote Similarity NPD1432 Clinical (unspecified phase)
0.6914 Remote Similarity NPD7472 Approved
0.6911 Remote Similarity NPD3028 Approved
0.6906 Remote Similarity NPD5736 Approved
0.6905 Remote Similarity NPD968 Approved
0.6879 Remote Similarity NPD3764 Approved
0.6879 Remote Similarity NPD6798 Discontinued
0.6875 Remote Similarity NPD9380 Clinical (unspecified phase)
0.6853 Remote Similarity NPD6355 Discontinued
0.6853 Remote Similarity NPD4340 Discontinued
0.685 Remote Similarity NPD290 Approved
0.6839 Remote Similarity NPD2977 Approved
0.6839 Remote Similarity NPD2978 Approved
0.6829 Remote Similarity NPD7251 Discontinued
0.6829 Remote Similarity NPD7685 Pre-registration
0.6829 Remote Similarity NPD7240 Approved
0.6828 Remote Similarity NPD7033 Discontinued
0.6828 Remote Similarity NPD4108 Discontinued
0.6824 Remote Similarity NPD4628 Phase 3
0.6815 Remote Similarity NPD3095 Discontinued
0.6806 Remote Similarity NPD5314 Approved
0.6792 Remote Similarity NPD7199 Phase 2
0.6791 Remote Similarity NPD7741 Discontinued
0.6788 Remote Similarity NPD2562 Approved
0.6788 Remote Similarity NPD7808 Phase 3
0.6788 Remote Similarity NPD2561 Approved
0.6783 Remote Similarity NPD3062 Approved
0.6783 Remote Similarity NPD3061 Approved
0.6783 Remote Similarity NPD3059 Approved
0.6783 Remote Similarity NPD4060 Phase 1
0.6768 Remote Similarity NPD6797 Phase 2
0.6763 Remote Similarity NPD4339 Clinical (unspecified phase)
0.6761 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6757 Remote Similarity NPD1652 Phase 2
0.6739 Remote Similarity NPD3685 Discontinued
0.6739 Remote Similarity NPD6583 Phase 3
0.6739 Remote Similarity NPD6582 Phase 2
0.6736 Remote Similarity NPD5735 Approved
0.6724 Remote Similarity NPD111 Approved
0.6718 Remote Similarity NPD5535 Approved
0.6715 Remote Similarity NPD5350 Clinical (unspecified phase)
0.6715 Remote Similarity NPD5351 Clinical (unspecified phase)
0.6713 Remote Similarity NPD6663 Approved
0.6711 Remote Similarity NPD4535 Phase 3
0.6709 Remote Similarity NPD7075 Discontinued
0.6692 Remote Similarity NPD6671 Approved
0.6691 Remote Similarity NPD9381 Approved
0.6691 Remote Similarity NPD9384 Approved
0.669 Remote Similarity NPD7095 Approved
0.6687 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7159 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3620 Phase 2
0.6667 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5283 Phase 1
0.6647 Remote Similarity NPD8313 Approved
0.6647 Remote Similarity NPD8312 Approved
0.6646 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6643 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6641 Remote Similarity NPD6124 Clinical (unspecified phase)
0.6641 Remote Similarity NPD228 Approved
0.6622 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6622 Remote Similarity NPD5763 Approved
0.6622 Remote Similarity NPD5762 Approved
0.6622 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6621 Remote Similarity NPD5124 Phase 1
0.6621 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6615 Remote Similarity NPD4750 Phase 3
0.6615 Remote Similarity NPD5451 Approved
0.6605 Remote Similarity NPD7184 Clinical (unspecified phase)
0.66 Remote Similarity NPD3400 Discontinued
0.6597 Remote Similarity NPD4404 Approved
0.6597 Remote Similarity NPD4062 Phase 3
0.6596 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6596 Remote Similarity NPD6584 Phase 3
0.6593 Remote Similarity NPD856 Approved
0.6593 Remote Similarity NPD16 Approved
0.6591 Remote Similarity NPD7635 Approved
0.6585 Remote Similarity NPD844 Approved
0.6585 Remote Similarity NPD1809 Phase 2
0.6579 Remote Similarity NPD7212 Phase 2
0.6579 Remote Similarity NPD7213 Phase 3
0.6577 Remote Similarity NPD1549 Phase 2
0.6577 Remote Similarity NPD2424 Discontinued
0.6575 Remote Similarity NPD2568 Approved
0.6575 Remote Similarity NPD6653 Approved
0.6573 Remote Similarity NPD4625 Phase 3
0.6566 Remote Similarity NPD7007 Discovery
0.6562 Remote Similarity NPD5048 Discontinued
0.6561 Remote Similarity NPD1934 Approved
0.6558 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6557 Remote Similarity NPD845 Approved
0.6552 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6552 Remote Similarity NPD5837 Clinical (unspecified phase)
0.6544 Remote Similarity NPD9545 Approved
0.6541 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6541 Remote Similarity NPD2234 Approved
0.6541 Remote Similarity NPD2229 Approved
0.6541 Remote Similarity NPD2228 Approved
0.6536 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6536 Remote Similarity NPD3536 Discontinued
0.6536 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6536 Remote Similarity NPD7447 Phase 1
0.6536 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6533 Remote Similarity NPD4236 Phase 3
0.6533 Remote Similarity NPD4237 Approved
0.6522 Remote Similarity NPD3847 Discontinued
0.6519 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6519 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6513 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6508 Remote Similarity NPD289 Clinical (unspecified phase)
0.65 Remote Similarity NPD9622 Approved
0.65 Remote Similarity NPD4749 Approved
0.65 Remote Similarity NPD2982 Phase 2
0.65 Remote Similarity NPD7876 Discontinued
0.65 Remote Similarity NPD2983 Phase 2
0.65 Remote Similarity NPD7975 Clinical (unspecified phase)
0.65 Remote Similarity NPD4379 Clinical (unspecified phase)
0.65 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6497 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6493 Remote Similarity NPD2629 Approved
0.6475 Remote Similarity NPD1535 Discovery
0.6475 Remote Similarity NPD422 Phase 1
0.6474 Remote Similarity NPD6056 Approved
0.6474 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6474 Remote Similarity NPD6057 Approved
0.6471 Remote Similarity NPD318 Approved
0.6471 Remote Similarity NPD317 Approved
0.6463 Remote Similarity NPD3052 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data